Product
Supplier
Encyclopedia
Inquiry
Home > Active Pharmaceutical Ingredients > Blood System Drugs (Find 85 items)

Blood System Drugs

Product List

Request for quotation , get quotes from more suppliers.

Heparin

(9005-49-6)
This product is the raw material for the preparation of anticoagulant heparin.

Product List

News

Request for quotation , get quotes from more suppliers.

Dabigatran etexilate mesylate

(872728-81-9)
Nonpeptide, direct thrombin inhibitor. Antithrombotic. Dabigatran etexilate mesylate is a raw material for the blood system; an anticoagulant drug; it can be used in patients with non-valvular atrial fibrillation to reduce the risk of stroke and systemic embolism; dabigatran etexilate is a new type of synthetic Direct thrombin inhibitor, a prodrug of dabigatran, is a non-peptide thrombin inhibitor. Security Information

Product List

Request for quotation , get quotes from more suppliers.

Argatroban

(74863-84-6)
Antithrombotic drugs. Synthetic thrombin inhibitor. It has a strong selective inhibitory effect on thrombin. Inhibit platelet aggregation caused by thrombin, weakly inhibit fibrinase, and promote fibrinolysis. For chronic arterial occlusion.

Product List

Request for quotation , get quotes from more suppliers.

Ozagrel

(82571-53-7)
Strong thromboxane synthase inhibitor. By inhibiting thromboxane synthase, it reduces thromboxane A, (TXA2), and promotes the production of prostacyclin (PGl2) to fight platelet aggregation and cerebral vasospasm, and other arachidene such as cyclooxygenase Acid metabolic enzymes have little effect. Clinically used for the treatment of cerebral spasm after subarachnoid hemorrhage and cerebral ischemia accompanied by cerebral spasm, and the improvement of dyskinesia associated with acute stage of

Product List

Request for quotation , get quotes from more suppliers.

Argatroban

(141396-28-3)
Anticoagulant.This anticoagulant (FW = 508.64 g/mol; CAS 74863-84-6), also named (2R,4R) -4-methyl-1-N2-[ (3-methyl-1,2,3,4-tetrahydro-8-quinolilyl) sulfon- yl]-L-arginyl-2-piperidine carboxylic acid, Novastan, and MD-805, is adirect thrombin inhibitor (1-11) that is an effective treatment for heparin- induced thrombocytopenia (HIT), an immunoglobulin-mediated adverse drug reaction characterized by platelet activation, thrombocytopenia, and a high risk of thrombotic complications among pati

Product List

Request for quotation , get quotes from more suppliers.

Etamsylate

(2624-44-4)
Hemostatic;prostaglandin synthesis inhibitor he product can increase the number, aggregation and adhesion of platelets, and promote the release of coagulation active substances from platelets. It can also accelerate the contraction of blood clots, shorten the clotting time, enhance the resistance of capillaries, and reduce capillary permeability. Used to prevent and treat bleeding before surgery. It is also used for bleeding caused by platelet insufficiency or other causes, such as gastrointest

Product List

Request for quotation , get quotes from more suppliers.

Propanoic acid, 2-hydroxy-, iron(2+) salt (2:1)

(5905-52-2)
Iron(II) Lactate is used in the iron fortification of food products, particularly milk products targeted for infants and toddlers.

Product List

Request for quotation , get quotes from more suppliers.

Deferasirox

(201530-41-8)
Labeled Deferasirox, intended for use as an internal standard for the quantification of Deferasirox by GC- or LC-mass spectrometry.

Product List

Request for quotation , get quotes from more suppliers.

Hematological diseases refer to diseases that are primary (such as leukemia) or mainly involve blood (such as iron deficiency anemia) and hematopoietic organs. Classification: red blood cell diseases, such as various types of anemia and polycythemia, etc .; granulocyte diseases, such as leukopenia and agranulocytosis, neutrophil lobular insufficiency, inert leukocyte syndrome, and leukemia-like reactions. Blood system drugs mainly include: anti-anemic drugs, leukocyte-raising drugs, antiplatelet drugs, procoagulant drugs, anticoagulant drugs and thrombolytic drugs, blood volume expansion agents, leukocyte-raising drugs, antiplatelet drugs and other drugs. The "Blood System Drugs" on ECHEMI classification list mainly supplies APIs for these drugs.
Complaint
Email:
Message:
Send Message